Arcadia Investment Advisors’s Sanofi SNY Stock Holding History

Arcadia Investment Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-28	Closed	-$1.47K	–	218
2021 Q2	$1.47K	Buy	+28	New	+$1.46K	﹤0.01%	144

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Arcadia Investment Advisors's SNY Position: Q3 2021 in Review

Arcadia Investment Advisors sold out of Sanofi (SNY) in Q3 2021, closing a stake of 28 shares — an estimated $1.47K sold.

Arcadia Investment Advisors first reported a position in SNY in Q2 2021 and held it in 1 quarter. The position peaked at $1.47K in Q2 2021. 576 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

Arcadia Investment Advisors reported no remaining Sanofi position as of Q3 2021 after selling out during the quarter.
Arcadia Investment Advisors sold 28 Sanofi shares in Q3 2021, an estimated $1.47K.
Arcadia Investment Advisors first reported a position in Sanofi in Q2 2021 and held it in 1 quarter.
Arcadia Investment Advisors's Sanofi position peaked at $1.47K in Q2 2021.
576 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on Arcadia Investment Advisors's 13F filing for Q3 2021, filed 19 Dec 2024.